http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1561112-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_406c0700760b8160d0f9ead3917c3017 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56961 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 |
filingDate | 2003-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8d95c88782982e658da616ce4aea67a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2264c275eccb8d05eeba37e66fd666b |
publicationDate | 2005-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-1561112-A1 |
titleOfInvention | Diagnosis of candidiasis and candidemia or invasive candida infection |
abstract | The use of an antibody to a C albicans cell wall antigen or to a solubilized phosphopeptidomannan (PPM) fraction of the cell wall of C albicans, or preferably a combination of an IgG2 antibody to a phosphopeptidomannan (PPM) fraction of the cell wall of C albicans, and an IgG1 or IgG3 antibody to a C albicans cell wall antigen in the diagnosis of candidiasis or invasive candidiasis is disclosed. Also diagnostic tests are disclosed. |
priorityDate | 2002-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 108.